Have any knowledge you can add to this?
ping
more here
The closing of the plant has affected everything from opioids to pet medications. It was Novartis' largest OTC manufacturing facility, producing its entire Excedrin line, as well as NoDoz, Bufferin and Gas-X Prevention products. The company had to recall millions of products. But it also made drugs like Percoset for Endo Health Solutions ($ENDP) and as well hypertension drugs for GlaxoSmithKline ($GSK).
The FDA raised serious concerns over manufacturing at the plant, which was closed in December. Among other problems, there was a chance that chipped particles of one drug made it into the bottles of other drugs. Investigators found unclean lines and more than 1,300 consumer complaints that had not been addressed. Originally, remediation at the plant was expected to be completed mid-year, but during an earnings call in April, executives said it is taking longer than expected. The company has shifted production of some products to other facilities but Canadians, and others, may have to turn elsewhere for Maalox.